Standard treatment for cluster headache consists of abortive treatment with oxygen, triptans, ergot alkaloids and/or topical nasal local anesthetic during acute episodes and preventive treatment such as steroid injections, calcium channel blockers and lithium. Although the exact pathophysiology of cluster headache is not well understood, reduced serum levels of kynurenine metabolites with anti-NMDA (N-methyl-D-aspartate) properties have been demonstrated. Ketamine and magnesium, which both have potent anti-NMDA receptor activity, have been used in multiple refractory pain syndromes. We describe a case of cluster headache that was non-responsive to standard therapy and treated effectively with intravenous infusion of magnesium and ketamine.
CITATION STYLE
Del Rey, M. L. P., Jiménez, M. B., Canuel, J. F., & Marchante, C. D. A. (2019). Antagonismo NMDA en el tratamiento de la cefalea en racimos. Revista de La Sociedad Espanola Del Dolor, 26(4), 247–250. https://doi.org/10.20986/resed.2019.3710/2018
Mendeley helps you to discover research relevant for your work.